安徽黄山胶囊股份有限公司发布2025年度利润分配预案公告

证券代码：002817
证券简称：黄山胶囊
公告日期：2026年3月20日

报告要点概述

• 公司2025年度利润分配预案已于第六届董事会第二次会议审议通过，尚需提交股东大会审议。
• 2025年度归属于上市公司股东的净利润为64,985,897.94元，母公司净利润为63,474,899.76元。
• 截至2025年12月31日，公司可供分配利润为500,095,668.14元，总股本为299,098,170股。
• 拟以2025年12月31日总股本为基数，向全体股东每10股派发现金红利0.53元（含税），共计派发现金红利15,852,203.01元（含税）。
• 2025年全年累计现金分红25,722,442.62元（含税），占净利润的39.58%。
• 本次分红不送红股，不以资本公积转增股本。
• 如股本发生变动，将按照“分配总额不变，调整分配比例”原则进行调整。
• 公司近三年年度现金分红总额分别为25,722,442.62元、19,441,381.05元、25,423,344.45元，三年累计现金分红70,587,168.12元，均高于三年平均净利润的30%。
• 公司未触及《股票上市规则》第9.8.1条规定的风险警示情形。
• 分红方案符合监管要求，考虑了公司成长性、资金需求及股东回报。
• 利润分配预案尚需股东大会审议，存在一定不确定性。

对投资者和股东的重要影响与价格敏感信息

• 高比例现金分红：2025年度分红金额占净利润近40%，显示公司盈利能力稳定且回报股东意愿强烈，或对股价构成积极影响。
• 持续高分红记录：近三年分红总额超三年平均净利润30%，表明公司具备良好的持续盈利与现金流能力。
• 不送红股、不转增股本：本次分红完全以现金形式进行，避免股本稀释，利于每股价值提升。
• 股本变动调整机制：若分红实施前公司股本发生变化，将调整分红比例，保持分红总额不变，保障股东权益。
• 政策合规性：分红方案符合证监会、公司章程及未来三年股东回报规划，与行业水平相符。
• 风险提示：分红预案尚未最终获股东大会批准，投资者需关注后续进展，理性投资。

详细财务数据与分红方案

2025年度分红方案：以2025年12月31日总股本299,098,170股为基数，每10股派发现金红利0.53元，合计分红15,852,203.01元（含税）。同时，前三季度已分红9,870,239.61元，全年累计分红25,722,442.62元，占净利润39.58%。

历史分红与风险警示

• 近三年年度现金分红分别为：25,722,442.62元、19,441,381.05元、25,423,344.45元。
• 三年累计现金分红70,587,168.12元。
• 公司上市已满三个完整会计年度，连续高比例分红，显示公司分红政策稳定。
• 公司各项指标均未触及风险警示，财务状况良好。

公司声明与后续事项

• 本次利润分配预案需股东大会审议后方可实施，存在一定不确定性，投资者需关注后续公告。
• 董事会已审议通过，审计报告及会议决议备查。

免责声明

本文基于安徽黄山胶囊股份有限公司官方公告整理，仅供投资参考。利润分配方案尚未最终实施，存在不确定性。投资者应结合自身风险承受能力，理性决策，本文不构成具体投资建议。

Anhui Huangshan Capsule Co., Ltd. Announces 2025 Profit Distribution Plan

Stock Code: 002817
Short Name: Huangshan Capsule
Date of Announcement: March 20, 2026

Key Points from the Report

• The company’s 2025 profit distribution plan was approved at the 6th Board’s 2nd meeting, pending shareholder approval.
• Net profit attributable to shareholders in 2025: RMB 64,985,897.94; parent company net profit: RMB 63,474,899.76.
• Distributable profit as of December 31, 2025: RMB 500,095,668.14; total shares outstanding: 299,098,170.
• Proposed cash dividend: RMB 0.53 (tax included) per 10 shares, totalling RMB 15,852,203.01 (tax included).
• Total cash dividends for 2025: RMB 25,722,442.62 (tax included), 39.58% of net profit.
• No bonus shares or capital reserve conversion; all dividends in cash.
• If share capital changes before distribution, the ratio will be adjusted to keep the total unchanged.
• Past three years’ cash dividends: RMB 25,722,442.62; RMB 19,441,381.05; RMB 25,423,344.45. Three-year total: RMB 70,587,168.12, more than 30% of average net profit.
• No risk warnings per stock listing rules.
• The plan complies with regulatory requirements and considers growth, capital needs, and shareholder returns.
• The plan is not yet finalized and is subject to shareholder approval.

Important and Price-Sensitive Information for Shareholders

• High Cash Dividend Ratio: Nearly 40% of net profit is being distributed, reflecting strong profitability and shareholder return, likely to positively impact share price.
• Consistent Dividend Record: Three-year cash dividend exceeds average net profit by 30%, showing sustained profitability and cash flow.
• No Bonus Shares/Conversion: All dividends are cash-based, avoiding dilution and potentially boosting per-share value.
• Adjustment Mechanism: If share capital changes, dividend ratio will adjust but total payout remains the same, protecting shareholder interests.
• Regulatory Compliance: Plan meets CSRC, company charter, and future shareholder return policy, consistent with industry norms.
• Risk Warning: Plan not yet finalized; investors should stay alert and invest rationally.

Detailed Financial Data and Distribution Plan

2025 Distribution Plan: Based on total shares of 299,098,170 as of December 31, 2025, cash dividend of RMB 0.53 per 10 shares (tax included), total RMB 15,852,203.01. With previous three quarters’ dividend of RMB 9,870,239.61, total annual dividend RMB 25,722,442.62, 39.58% of net profit.

Dividend History and Risk Warning

• Annual cash dividends for past three years: RMB 25,722,442.62; RMB 19,441,381.05; RMB 25,423,344.45.
• Three-year total cash dividend: RMB 70,587,168.12.
• Company has been listed for three full fiscal years, maintaining stable dividend policy.
• All indicators show no risk warnings; financial status is solid.

Company Statement and Next Steps

• This profit distribution plan requires shareholder approval before implementation; uncertainty remains, investors should monitor updates.
• Board resolutions and audit reports are available for inspection.

Disclaimer

This article is based on official announcements from Anhui Huangshan Capsule Co., Ltd. and is for investment reference only. The dividend plan is not yet finalized and subject to change. Investors should evaluate their own risk tolerance and make rational decisions. This article does not constitute specific investment advice.

View 黄山胶囊 Historical chart here